[ad_1]
- Volpara’s Affected person Hub™ will ship complex mammography reporting and possibility evaluate to make stronger breast most cancers screening throughout army condition amenities
LYNNWOOD, Wash., Nov. 4, 2024 /PRNewswire/ — Volpara Condition, a Lunit corporate and a world chief in device for the early detection of most cancers, as of late introduced a vital word of honour with the U.S. Protection Condition Company (DHA) valued at $7.3 million over 5 years. The word of honour will see Volpara’s Affected person Hub™, a complicated mammography reporting, most cancers possibility evaluate and affected person monitoring machine, deployed throughout DHA’s army condition machine. The purpose is to modernize breast most cancers screening and affected person control for army group of workers and their households.
The DHA is a part of the U.S. Area of Protection and is answerable for healthcare products and services for about 9.6 million active-duty army participants, retirees, and their households around the Military, Army, Wind Drive, and Marines.
Turning in Fashionable Breast Most cancers Screening
Volpara’s Affected person Hub integrates essential sides of breast condition control, together with scheduling knowledge assortment, possibility evaluate and mammogram monitoring. Those options safeguard that healthcare suppliers can ship personalised, well timed assist thru automatic follow-ups, reminders, and affected person communications. Affected person Hub reduces administrative burdens, streamlines workflow and facilitates adherence to breast condition pointers—all important to making improvements to early detection and breast most cancers results.
“Working with the Defense Health Agency is a tremendous opportunity to improve healthcare for those who serve our nation,” stated Teri Thomas, CEO of Volpara and CBO of Lunit. “Achieving certification to meet the Department of Defense’s rigorous security standards demonstrates our commitment to patient care and data security. We look forward to providing state-of-the-art solutions that make a difference in breast health outcomes.”
This word of honour marks a vital milestone for Volpara and its ongoing venture to walk breast condition thru state-of-the-art era. Earlier generations of the corporate’s mammography reporting device had been in utility through the Area of Protection since 1990.
About Volpara Condition
Volpara Condition is on a venture to save lots of households from most cancers with AI-powered device that is helping healthcare suppliers higher perceive most cancers possibility, information personalised assist selections, and counsel supplementary imaging and interventions. Old in over 2,000 amenities through greater than 5,600 technologists international. Volpara’s device affects just about 17M sufferers, helps over 3M annual most cancers possibility exams, and integrates seamlessly with digital condition information and imaging methods. Volpara is helping radiologists quantify vague breast tissue with precision and technologists manufacture mammograms with optimum positioning, compression, and dose. Volpara device additionally streamlines operations to diversion compliance and accreditation. Volpara, a Lunit corporate, is headquartered in Wellington, Pristine Zealand, and has an workplace in Seattle. Volpara is the depended on spouse of eminent healthcare establishments globally. For more info, consult with www.volparahealth.com.
Media Touch: Andrew Thompson-Younger, [email protected]
SOURCE Volpara Condition, Inc.
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Retailers
270k+
Reporters
Opted In
[ad_2]
Source link
